Panacea Life Sciences Holdings, Inc. Marketable Securities, Unrealized Gain (Loss)
Panacea Life Sciences Holdings, Inc. (PLSH) reported Marketable Securities, Unrealized Gain (Loss) of $5.05 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-06.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2024-05-06
- Panacea Life Sciences Holdings, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2024-03-31 was $5.05K.
- Panacea Life Sciences Holdings, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2023-12-31 was -$63.49K.
- Panacea Life Sciences Holdings, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2023-09-30 was -$381.97K.
- Panacea Life Sciences Holdings, Inc. marketable securities, unrealized gain (loss) for the quarter ending 2023-06-30 was -$464.72K.
- Panacea Life Sciences Holdings, Inc. marketable securities, unrealized gain (loss) for fiscal 2023 was -$1.09M.
- Panacea Life Sciences Holdings, Inc. marketable securities, unrealized gain (loss) for fiscal 2022 was -$2.66M, a 363.89% decline from fiscal 2021.
- Panacea Life Sciences Holdings, Inc. marketable securities, unrealized gain (loss) for fiscal 2021 was $1.01M, a 29.35% decline from fiscal 2020.
- Panacea Life Sciences Holdings, Inc. marketable securities, unrealized gain (loss) for fiscal 2020 was $1.43M.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 6 month as first filed | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | $5.05K 10-Q · filed 2024-05-06 | -$58.43K derived: sum of 2 quarters · filed 2024-05-06 | -$440.40K derived: sum of 3 quarters · filed 2024-05-06 | -$905.12K derived: sum of 4 quarters · filed 2024-05-06 | |
| 2023-12-31 | -$63.49K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$445.45K derived: sum of 2 quarters · filed 2024-04-01 | -$910.17K derived: sum of 3 quarters · filed 2024-04-01 | -$1.09M 10-K · filed 2024-04-01 | |
| 2023-09-30 | -$381.97K 10-Q · filed 2023-11-14 | -$846.69K derived: sum of 2 quarters · filed 2023-11-14 | -$1.03M 10-Q · filed 2023-11-14 | -$1.04M derived: sum of 4 quarters · filed 2024-05-06 | |
| 2023-06-30 | -$464.72K 10-Q · filed 2023-08-15 | -$646.97K 10-Q · filed 2023-08-15 | -$655.15K derived: sum of 3 quarters · filed 2024-05-06 | -$2.10M derived: sum of 4 quarters · filed 2024-05-06 | |
| 2023-03-31 | -$182.25K 10-Q · filed 2024-05-06 | -$190.44K derived: sum of 2 quarters · filed 2024-05-06 | -$1.64M derived: sum of 3 quarters · filed 2024-05-06 | -$1.90M derived: sum of 4 quarters · filed 2024-05-06 | |
| 2022-12-31 | -$8.18K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$1.46M derived: sum of 2 quarters · filed 2024-04-01 | -$1.72M derived: sum of 3 quarters · filed 2024-04-01 | -$2.66M 10-K · filed 2024-04-01 | |
| 2022-09-30 | -$1.45M 10-Q · filed 2023-11-14 | -$1.71M derived: sum of 2 quarters · filed 2023-11-14 | -$2.65M 10-Q · filed 2023-11-14 | -$2.49M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$260.27K 10-Q · filed 2023-08-15 | -$1.21M 10-Q · filed 2023-08-15 | -$1.05M derived: sum of 3 quarters · filed 2023-08-15 | -$3.35M derived: sum of 4 quarters · filed 2023-08-15 | |
| 2022-03-31 | -$944.80K 10-Q · filed 2023-05-12 | -$785.29K derived: sum of 2 quarters · filed 2023-05-12 | -$3.09M derived: sum of 3 quarters · filed 2023-05-12 | -$1.35M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $159.51K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$2.14M derived: sum of 2 quarters · filed 2023-03-30 | -$405.70K derived: sum of 3 quarters · filed 2023-03-30 | $1.01M 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$2.30M 10-Q · filed 2022-11-14 | -$565.22K derived: sum of 2 quarters · filed 2022-11-14 | $848.53K 10-Q · filed 2022-11-14 | $2.87M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $1.74M 10-Q · filed 2022-08-15 | $3.15M 10-Q · filed 2022-08-15 | $5.17M derived: sum of 3 quarters · filed 2022-08-15 | $5.01M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $1.41M 10-Q · filed 2022-05-13 | $3.44M derived: sum of 2 quarters · filed 2022-05-13 | $3.28M derived: sum of 3 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $2.02M derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | $1.86M derived: sum of 2 quarters · filed 2022-03-31 | $1.43M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | -$160.31K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2021-12-20 | -$595.59K 10-Q/A · filed 2021-12-20 | |||
| 2020-06-30 | -$435.28K 10-Q/A · filed 2021-12-20 | -$305.58K 10-Q · filed 2021-08-23 |